These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4323739)

  • 1. ACTH-induced adrenocortical response patterns in multiple sclerosis and their relation to the clinical effectiveness of ACTH therapy.
    Alexander L; Cass LJ
    Confin Neurol; 1971; 33(1):1-24. PubMed ID: 4323739
    [No Abstract]   [Full Text] [Related]  

  • 2. Pituitary adrenocortical function in multiple sclerosis.
    Cazzullo CL; Piotti LE; Montanini R; Montalbetti N; Bonini PA; Marforio S
    Life Sci; 1968 Feb; 7(3):137-44. PubMed ID: 4295758
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenocorticotrophic potency of long-acting corticotrophin preparations during long-term treatment of neurological patients.
    Rinne UK
    Ann Med Intern Fenn; 1968; 57(4):167-72. PubMed ID: 4307479
    [No Abstract]   [Full Text] [Related]  

  • 4. The assessment of adrenal-cortical function in patients receiving corticotrophin therapy.
    Levell MJ; Stitch SR; Noronha M; Vas C
    Acta Endocrinol (Copenh); 1970 Jun; 64(2):287-94. PubMed ID: 4317517
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies of the effect of ACTH prolongatum Polfa and corticotropin Organon on the function of the adrenal cortex].
    Mazanek E; Buntner B
    Pol Tyg Lek; 1971 Aug; 26(31):1203-5. PubMed ID: 4328805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical tests of a new long-acting form of synthetic ACTH: Cortrosyn Depot].
    Libon JC; Borlée J
    Rev Med Liege; 1969 Nov; 24(21):762-5. PubMed ID: 4316477
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of adrenocortical reserves with long-acting corticotropin preparations in the two-day intramuscular corticotropin test in man.
    Pekkarinen A; Rinne UK
    Scand J Clin Lab Invest Suppl; 1967; 100():127. PubMed ID: 4292205
    [No Abstract]   [Full Text] [Related]  

  • 8. Corticotrophin treatment in multiple sclerosis.
    Rinne UK; Sonninen V; Tuovinen T
    Acta Neurol Scand; 1968; 44(2):207-18. PubMed ID: 4301249
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenal hemorrhage complicating ACTH therapy in Crohn's disease.
    Levin TL; Morton E
    Pediatr Radiol; 1993; 23(6):457-8. PubMed ID: 8255651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The currently suitable laboratory diagnosis of the adrenal gland cortex function].
    Müller J
    Schweiz Med Wochenschr; 1967 Oct; 97(41):1359-61. PubMed ID: 4299053
    [No Abstract]   [Full Text] [Related]  

  • 11. Adrenocortical secretion capacity during long-term corticotrophin treatment of neurological patients.
    Kytömäki O; Rinne UK
    Acta Neurol Scand; 1970; 46(S43):263-4. PubMed ID: 4318676
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic and therapeutic use of synthetic beta 1-24 corticotropin (30'920-BA Synacthen Ciba)].
    Horký K; Küchel O
    Vnitr Lek; 1968 Apr; 14(4):370-9. PubMed ID: 4298653
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of adrenal gland function in multiple sclerosis].
    Zibetti A; Smeraldi E; Paltrinieri E
    Acta Neurol (Napoli); 1972; 27(2):108-13. PubMed ID: 5042255
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of aminoglutethimide in a case of ectopic ACTH syndrome. Influence on steroid metabolism.
    McMillan M; Maisey MN
    Acta Endocrinol (Copenh); 1970 Aug; 64(4):676-86. PubMed ID: 4318105
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies on the stimulation and suppression of the pituitary-adrenocortical system. I. Studies on the adrenocortical-stimulating effects of synthetic beta-1-24 ACTH preparations].
    Sako Y
    Nihon Naibunpi Gakkai Zasshi; 1968 Dec; 44(9):1007-15. PubMed ID: 4304527
    [No Abstract]   [Full Text] [Related]  

  • 16. [Criteria for evaluating adrenal cortical reserves by the ACTH test].
    Khazanov MM
    Probl Endokrinol (Mosk); 1972; 18(5):110-8. PubMed ID: 4367011
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical application of a new synthetic ACTH, DW-75 (D-serine-1-norleucine-4-valinamide-25-beta-1-25-corticotropin)].
    Matsumoto Y; Isurugi K; Kinoshita K; Takayasu H
    Nihon Naibunpi Gakkai Zasshi; 1970 Aug; 46(5):534-8. PubMed ID: 4318387
    [No Abstract]   [Full Text] [Related]  

  • 18. [Response of the adrenal gland cortex to synthetic ACTH (30.920-Ba) in normal patients and those with endocrine disorders].
    Schnitman DS; De Lapacó EK; Rozenfeld L
    Rev Argent Endocrinol Metab; 1966 Dec; 12(4):244-54. PubMed ID: 4298849
    [No Abstract]   [Full Text] [Related]  

  • 19. Endocrine activity in multiple sclerosis.
    Teasdale GM; Smith PA; Wilkinson R; Latner AL; Miller H
    Lancet; 1967 Jan; 1(7481):64-8. PubMed ID: 4163053
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a synthetic 25 amino acid corticotrophin in normal man.
    Rose LI; Williams GH; Jagger PI; Lauler DP
    Clin Pharmacol Ther; 1968; 9(6):740-4. PubMed ID: 4301829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.